Thank you

If the GLD is now breaking down from the small bear flag pattern, do it measure down to 147ish?  I was just looking at Steve's daily chart from last night

Looking at the volume patterns in the S&P 500 since August 1st shows that volume has increased on declines and decreased during the reaction rallies.  The up and down moves have been on average 7 days in length...so this last move is now 10 trading days long.  Couple that with Matt and Steve's wave counts and marketguy's negative divergence....I would think next week should be to the downside.

This is one I have been watching.  The 13/34 are flat together and BB are tightening.  The stock had a really good run earlier in the year and now after the correction looks ready to pop.

I have been trying to get an image to upload too...but no luck.  I was referring to the futures chart.  The left shoulder formed around 5am this morning with the head around 8:30am we are working on the right shoulder now.

It appears the neckline at 1206 and break measures down to 1196

Neoprobe continues to provide a good amount of upside potential, as it is very close to filing a new drug application with the FDA and has recently moved onto a major stock exchange.  Over the next 12 months, Neoprobe Corporation has a chance to go from producing 10 million in annual revenue to over $450 million in annual revenue.  Over the next 2-3 years, there is even greater potential for Neoprobe Corp to produce over $2-3 billion in annual revenue.  NEOP has remained stable as the underlying market is being whipped around. On NEOP, there are open interests of 30987 option calls (bullish) at various strike prices and there are open interests of 1223 option puts (bearish) at various strike prices.  So the ratio there is like 30:1, which needless to say is bullish on the underlying stock price.  If that ratio were flip flopped, that would be bearish on the stock.   We are within 30 days of top line data on the last Lymphoseek trial, 45-60 days from New Drug Application filing for Lymphoseek, 90-180 days from approved trial design for RIGScan CR phase 3 trial, 6-9 months from Lymphoseek approval and 10-12 months from RIGScan CR phase 3 trial.  I do not see anything negative for the next 12 months. 

If it was restricted I would assume that we should see a higher put volume then call volume on the stock, but today was the opposite.

National Inflation Assocation

Here is one I keep following that is breaking out after some consolidation

Japanese stocks jump as G-7 reportedly approves forex intervention; Nikkei Average up 2.4%
03/17/2011 08:04:53 PM

If you click on the GDX Swing System and scroll down there is a section above the graph that updates hourly the status of the BPGDM

It appears from looking at the GDX Swing System intraday monitor that BPGDM will have no change from yesterday.  Is this correct?

Thanks

China's consumer price index rose 4.9% in January from a year earlier, the National Bureau of Statistics said Tuesday, adding that it had reweighted components in the index. The result was below forecast, but the producer price index, which rose 6.6%, climbed more quickly than expected. Average forecasts for CPI had called for a gain of 5.4% and a PPI rise of 6.3%, according to a survey of economists reported by Dow Jones Newswires. The CPI reading also matched exactly whispered numbers that had appeared in some news reports Monday. In December, consumer prices rose 4.6% year-on-year, while wholesale prices were up 5.9%. While the Statistics Bureau said it had reconfigured the CPI, it added that the new weightings added rather than subtracted from the inflation rate for January.

Thank you...just got it.

I appreciate the good work!

Matt this most definitely will be a buy signal...correct?